Intralesional collagenase in the treatment of Peyronie’s disease
Honig SC. Intralesional collagenase in the treatment of Peyronie’s disease. Therapeutic Advances In Urology 2013, 6: 47-53. PMID: 24688600, PMCID: PMC3943365, DOI: 10.1177/1756287213509849.Peer-Reviewed Original ResearchPeyronie's diseaseEvidence of efficacyMinimal side effectsUnited States FoodPharmacologic agentsFirst drugLarge dosesSide effectsDrug AdministrationDiseaseEuropean AssociationStates FoodSexual medicineTreatmentWound remodelingCollagenaseCurrent dataPharmacotherapyGradeVerapamilInterferonLocal effectsAgentsSteroidsAdministration